If You'd Invested $1,000 in AbbVie (ABBV) Stock 10 Years Ago, Here's How Much You'd Have TodayThe Motley Fool • 08/03/25
Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challengesWSJ • 08/01/25
Dividend Aristocrats: 4 Companies That Surpass Market Volatility With 25 Plus Years of Growth and Superior Yields24/7 Wall Street • 08/01/25
AbbVie Beats on Q2 Earnings & Sales, Stock Up on Raised '25 EPS ViewZacks Investment Research • 07/31/25
AbbVie Announces Positive Topline Results from Phase 3 UP-AA Trial Evaluating Upadacitinib (RINVOQ®) for Alopecia AreataPRNewsWire • 07/30/25
4 Safe High-Yielding Dividend Aristocrats Are Our Top Picks in a Dangerous Market24/7 Wall Street • 07/30/25